Browse Category

NASDAQ:BSX News 21 January 2026

Boston Scientific stock steadies after FDA flags AXIOS stent issue; Penumbra deal still in play

Boston Scientific stock steadies after FDA flags AXIOS stent issue; Penumbra deal still in play

New York, January 21, 2026, 11:55 AM EST — Regular session Shares of Boston Scientific Corporation held steady, edging just above $91.20 during late morning trading in New York on Wednesday. The stock is steady, with investors weighing a device-safety warning from U.S. regulators while watching Boston Scientific’s latest deal moves. Attention remains on the company’s planned Penumbra acquisition, sparking…

Stock Market Today

  • ASX 200 set to open higher after US relief rally, OECD warns on Australia's fiscal outlook
    January 21, 2026, 2:52 PM EST. Australian shares are poised to open sharply higher, following Wall Street's relief rally sparked by US President Donald Trump's comments on Greenland and a new 'framework' agreement with Denmark. ASX 200 futures rose 0.5% to 8793. The OECD urged faster fiscal reforms in Australia to address swelling federal deficits and rising debt-to-GDP ratios. The Reserve Bank's neutral rate estimate is 3.1%, below the current 3.6% cash rate. Key market data includes a stronger AUD at 67.58 US cents and Bitcoin steady above $90,000. Investors await December jobs data with unemployment expected steady at 4.3%. Major companies like Fortescue and Santos are reporting quarterly updates. Political turmoil continued as all 11 Nationals MPs resigned from the shadow ministry, threatening Coalition stability.
Go toTop